News
TipRanks on MSN11h
PDS Biotechnology Publishes Versamune® HPV Abstracts at ASCOPDS Biotechnology ( ($PDSB) ) has shared an update. On June 2, 2025, PDS Biotechnology Corporation announced the publication of three Versamune® ...
TipRanks on MSN11h
BioAtla presents Phase 2 Oz-V clinical trial data at ASCO 2025BioAtla (BCAB) announced data in a poster titled, “Phase 2 Trial of Ozuriftamab Vedotin, a Conditionally Binding CAB-ROR2-ADC, in Patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback